1. Market Research
  2. > Pharmaceutical Market Trends
Ukraine Pharmaceutical & Healthcare Industries Overview 2018

Ukraine Pharmaceutical & Healthcare Industries Overview 2018

  • March 2018
  • 32 pages
  • ID: 5365319
  • Format: PDF
  • By UPharma Consulting


Table of Contents

Search Inside

Ukraine is located in the Eastern Europe connecting Russia to the East and the EU countries such as Poland, Romania, Hungary, Slovakia to the west. Ukraine is the biggest European country by the territory (excluding Russia) and the 7th country by population. The country is seen as lower middle-income state. In 2016, the GDP of Ukraine amounted USD 92.8 bn making it the 23rd country in Europe by economy size.

2016 was expected to be a crucial year in Ukrainian reforms process. Relative political stability, sufficient public support, concentration of power in one single policymaking center, low intensity of the conflict in Donbas, strong and solid foreign assistance – all of it created conducive and favorable conditions for a breakthrough in reforms and modernization of the country.

In Q32017, Ukraine’s economy grew 2.1% y-o-y, down slightly from 2.3% in Q2 and 2.5% in Q1. The last quarter of the year showed the worst growth dynamics, but an improving service sector remained strong enough to compensate for a significant drop in agriculture and industry. According to a provisional estimate of the NBU, Ukraine’s 2017 GDP grew 2.1% y-o-y.

Pharmaceutical market
Since 2009, the Ukrainian pharmaceutical market had been growing by about 13% y-o-y in values and 3% y-o-y in volumes annually. New challenges emerged as a result of the consequences of the war conflict and the loss of occupied territories – Crimea and parts of Donetsk and Luhansk regions, which made about of 20.7% of the total retail pharmaceutical market in values in the pre-crisis year. The fall of the purchase power of the population increased the demand for cheaper drugs.

All market participants suffered losses during the crisis period, especially foreign companies – some of them had to leave the market. The market showed first signs of the recovering only in the mid-2016. In 2017 it showed considerable growth dynamics, but the level of 2013 was still far. After falling by 44% in 2014-2015, production of basic pharmaceutical products and drugs recovered by 9.8% y-o-y in 2016 and by 6.7% y-o-y in 2017.

Ukraine has strong local manufacturers of pharmaceuticals. TOP-5 most competitive Ukrainian companies – Farmak, Arterium Corporation, Darnitsa, Zdorovie Group and Kyiv Vitamin Factory – held almost 20% of the retail drug market in values in 2017. Totally, there are about 160 pharmaceutical companies in Ukraine, however, most of them are repackaging instead of selfmanufacturing.

As on the beginning of 2018, there were almost 20.5 ths retail PoS in Ukraine, which consisted of pharmacies (79.1%) and pharmacy units (20.9%).

The report covers a 2012-1HY2017 data with the forecast of the economics and pharmaceutical market growth to 2018-2019.
The forecast for 2019-2020 is more unpredictable as it’s concerned with indistinct development of the political situation in Ukraine. Prevention of internal and external risks would contribute to stable economic development and allow the pharmaceutical market to grow at the average level of 7-10% in values annually. Market participants and experts anticipate Ukraine to return to the Pharmerging Markets group by 2020.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Endometriosis - Pipeline Review, H2 2019

Endometriosis - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Endometriosis - Pipeline Review, H2 2019SummaryThis latest Pharmaceutical and Healthcare disease pipeline guide Endometriosis - Pipeline Review, H2 2019, provides an overview of the Endometriosis (Women’s ...

Celiac Disease - Pipeline Review, H2 2019

Celiac Disease - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Celiac Disease - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Celiac Disease - Pipeline Review, H2 2019, provides an overview of the Celiac Disease (G ...

Blood Disease Drugs Markets in China

Blood Disease Drugs Markets in China

  • $ 4000
  • October 2019

China’s demand for Blood Disease Drugs has grown at a fast pace in the past decade.In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth ...


Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on